A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

Some cancer patients who took 'checkpoint inhibitors' and received the COVID-19 vaccine saw surprising results.

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...

A: A Democratic proposal would restore almost $5 billion in unused funding for foreign aid that President Donald Trump let expire on Sept. 30. The proposal did not specify which international projects ...

Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all ...

Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s full-year ...

Public interest has recently turned to the human eye and the Pfizer COVID-19 Vaccine. Two peer-reviewed papers have helped ...

Computer scientist and futurist Ray Kurzweil believes humanity will achieve “longevity escape velocity” in just four years.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...